Common Stock, Shares Authorized of Astrana Health, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Astrana Health, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2010 to Q3 2025.
  • Astrana Health, Inc. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 100,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Astrana Health, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 100,000,000 0 0% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 100,000,000 0 0% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 100,000,000 0 0% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 100,000,000 0 0% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 100,000,000 0 0% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 100,000,000 0 0% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 100,000,000 0 0% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 100,000,000 0 0% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 100,000,000 0 0% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 100,000,000 0 0% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 100,000,000 0 0% 31 Mar 2023 10-Q/A 09 Aug 2023 2023 Q1
Q4 2022 100,000,000 0 0% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 100,000,000 0 0% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 100,000,000 0 0% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 100,000,000 0 0% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 100,000,000 0 0% 31 Dec 2021 10-K/A 09 Aug 2023 2022 FY
Q3 2021 100,000,000 0 0% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 100,000,000 0 0% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 100,000,000 0 0% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 100,000,000 0 0% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 100,000,000 0 0% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 100,000,000 0 0% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 100,000,000 0 0% 31 Mar 2020 10-Q 29 May 2020 2020 Q1
Q4 2019 100,000,000 0 0% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 100,000,000 0 0% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 100,000,000 0 0% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 100,000,000 0 0% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 100,000,000 0 0% 31 Dec 2018 10-K 16 Mar 2020 2019 FY
Q3 2018 100,000,000 0 0% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 100,000,000 0 0% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 100,000,000 0 0% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 100,000,000 0 0% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 100,000,000 0 0% 30 Sep 2017 10-Q 14 Nov 2017 2018 Q2
Q2 2017 100,000,000 0 0% 30 Jun 2017 10-Q 14 Aug 2017 2018 Q1
Q1 2017 100,000,000 0 0% 31 Mar 2017 10-Q 14 Nov 2017 2018 Q2
Q4 2016 100,000,000 0 0% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 100,000,000 0 0% 30 Sep 2016 10-Q 14 Nov 2016 2017 Q2
Q2 2016 100,000,000 0 0% 30 Jun 2016 10-Q 15 Aug 2016 2017 Q1
Q1 2016 100,000,000 0 0% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 100,000,000 0 0% 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 100,000,000 0 0% 30 Sep 2015 10-Q 17 Nov 2015 2016 Q2
Q2 2015 100,000,000 0 0% 30 Jun 2015 10-Q 28 Aug 2015 2016 Q1
Q1 2015 100,000,000 0 0% 31 Mar 2015 10-K 29 Jun 2016 2016 FY
Q4 2014 100,000,000 0 0% 31 Dec 2014 10-Q 23 Feb 2015 2015 Q3
Q3 2014 100,000,000 0 0% 30 Sep 2014 10-Q 14 Nov 2014 2015 Q2
Q2 2014 100,000,000 0 0% 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 100,000,000 0 0% 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q4 2013 100,000,000 0 0% 31 Jan 2014 10-K 14 Jul 2015 2015 FY
Q3 2013 100,000,000 0 0% 31 Oct 2013 10-Q 20 Dec 2013 2013 Q3
Q2 2013 100,000,000 0 0% 31 Jul 2013 10-Q 20 Dec 2013 2013 Q3
Q1 2013 100,000,000 0 0% 30 Apr 2013 10-Q 14 Jun 2013 2013 Q1
Q4 2012 100,000,000 0 0% 31 Jan 2013 10-K 08 May 2014 2013 FY
Q3 2012 100,000,000 0 0% 31 Oct 2012 10-Q 17 Dec 2012 2012 Q3
Q2 2012 100,000,000 0 0% 31 Jul 2012 10-Q 14 Sep 2012 2012 Q2
Q1 2012 100,000,000 30 Apr 2012 10-Q 19 Jun 2012 2012 Q1
Q4 2011 100,000,000 0 0% 31 Jan 2012 10-K 01 May 2013 2012 FY
Q3 2011 100,000,000 31 Oct 2011 10-Q/A 10 Apr 2012 2011 Q3
Q2 2011 100,000,000 31 Jul 2011 10-Q/A 10 Apr 2012 2011 Q2
Q4 2010 100,000,000 31 Jan 2011 10-K 15 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.